Characterization and Detection of Endolysin Gene from Three Acinetobacter baumannii Bacteriophages Isolated from Sewage Water

Indian Journal of Microbiology

Volumn 54, Issue 4, 2014, Pages 383-388

  Kitti, Thawatchai ^a   Thummeepak, Rapee ^b   Thanwisai, Aunchalee ^b   Boonyodying, Kamala ^b   Kunthalert, Duangkamol ^b   Ritvirool, Pannika ^b   Sitthisak, Sutthirat ^b  

^a Department of Science   (Thailand)

^b NARESUAN UNIVERSITY   (Thailand)

Author keywords

Acinetobacter baumannii; Bacteriophage; Endolysin

Indexed keywords

ACINETOBACTER BAUMANNII; MYOVIRIDAE; PODOVIRIDAE;

EID: 84918802390     PISSN: 00468991     EISSN: 09737715     Source Type: Journal    
DOI: 10.1007/s12088-014-0472-x     Document Type: Article

References (30)

1. Choi WS, Kim SH, Jeon EG, Son MH, Yoon KY et al (2010) Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program. J Korean Med Sci 25:999–1004
2. Bergogne-Berezin E, Towner KJ (1996) Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9:148–165
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317
4. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA (2007) Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51:3471–3484
5. Lu TK, Koeris MS (2011) The next generation of bacteriophage therapy. Curr Opin Microbiol 14:524–531
6. Soothill JS (1992) Treatment of experimental infections of mice with bacteriophages. J Med Microbiol 37:226–258
7. Wills QF, Kerrigan C, Soothill JS (1992) Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob Agents Chemother 49:1220–1221
8. McVay CS, Velásquez M, Fralick JA (2007) Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother 51:1934–1938
9. Morello E, Saussereau E, Maura D, Huerre M, Lhousseine T, Laurent D (2011) Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One 6:1–9
10. Borysowski J, Weber-Dabrowska B, Górski A (2006) Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med 231:366–377
11. Fischetti VA (2010) Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol 300:357–362
12. Hermoso JA, García JL, García P (2007) Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr Opin Microbiol 10:461–472
13. Lai MJ, Lin NT, Hu A, Soo PC, Chen LK, Chen LH, Chang KC (2011) Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria. Appl Microbiol Biotechnol 90:529–539
14. Lin NT, Chiou PY, Chang KC, Chen LK, Lai MJ (2010) Isolation and characterization of phi AB2: a novel bacteriophage of Acinetobacter baumannii. Res Microbiol 161:308–314
15. Yang H, Liang L, Lin S, Jia S (2010) Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol 10:131
16. Lee CN, Tseng TT, Lin JW, Fu YC, Weng SF, Tseng YH (2011) Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2. Appl Environ Microbiol 77:6755–6762
17. Jeon J, Kim JW, Yong D, Lee K, Chong Y (2012) Complete genome sequence of the podoviral bacteriophage YMC/09/02/B1251 ABA BP, which causes the lysis of an OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolate from a septic patient. J Virol 86:12437–12438
18. Jin J, Li ZJ, Wang SW, Wang SM, Huang DH et al (2012) Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol 12:156
19. Popova AV, Zhilenkov EL, Myakinina VP, Krasilnikova VM, Volozhantsev NV (2012) Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. FEMS Microbiol Lett 332:40–46
20. Shen GH, Wang JL, Wen FS, Chang KM, Kuo CF et al (2012) Isolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii. PLoS One 7:1–10
21. Thawal ND, Yele AB, Sahu PK, Chopade BA (2012) Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm. Curr Microbiol 65:66–72
22. Yele AB, Thawal ND, Sahu PK, Chopade BA (2012) Novel lytic bacteriophage AB7-IBB1 of Acinetobacter baumannii: isolation, characterization and its effect on biofilm. Arch Virol 157:1441–1450
23. Chang KC, Lin NT, Hu A, Lin YS, Chen LK, Lai MJ (2012) Genomic analysis of bacteriophage ϕAB1, a ϕKMV-like virus infecting multidrug-resistant Acinetobacter baumannii. Genomics 97:249–255
24. Huang G, Le S, Peng Y, Zhao Y, Yin S, Zhang L, Yao X, Tan Y, Li M, Hu F (2013) Characterization and genome sequencing of phage Abp1, a new phiKMV-like virus infecting multidrug-resistant Acinetobacter baumannii. Curr Microbiol 66:535–543
25. Niumsup PR, Boonkerd N, Tansawai U, Tiloklurs M (2009) Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand. Jpn J Infect Dis 62:152–154
26. Adams MH (1959) Bacteriophages. Inter science Publishers Inc, NewYork
27. Kutter E, Sulakvelidze A (2005) Bacteriophages: biology and applications. CRC Press, USA
28. Clokie MRJ, Kropinski AM (2009) Bacteriophages: methods and protocols, volume 2: molecular and applied aspects, vol 502. Humana Press, Totowa
29. Ackermann HW (2001) Frequency of morphological phage descriptions in the year 2000: brief review. Arch Virol 146:843–857
30. Bernhardt TG, Wang IN, Struck DK, Young R (2001) A protein antibiotic in the phage Qbeta virion: diversity in lysis targets. Science 292:2326–2329